8-K: Aclarion Inc. Secures $116,000 in At-the-Market Offering

Aclarion Inc. has entered into a subscription agreement to sell 400,000 shares of common stock at $0.29 per share, raising $116,000.

Summary

• Aclarion Inc. entered into a subscription agreement on August 12, 2024, with an institutional investor.
• The company agreed to sell 400,000 shares of common stock at a price of $0.29 per share.
• This transaction resulted in gross proceeds of $116,000 for Aclarion.
• The shares were offered at-the-market under Nasdaq rules, pursuant to the company's Form 1-A.
• The Form 1-A was initially filed on June 11, 2024, and qualified on June 24, 2024.
• No placement agent was involved, and no fees or commissions will be paid.
• Aclarion has the potential to raise an additional $29.68 million under the same terms and conditions.
• Future sales will be disclosed through subsequent Prospectus Supplements.
• The company currently has no additional agreements for future sales and cannot guarantee they will occur.

Sentiment

Score: 6

Explanation: The document indicates a successful, albeit small, capital raise with the potential for more. The lack of guarantees on future sales and the small initial amount temper the positive sentiment.

Positives

• Aclarion successfully raised $116,000 through a share offering.
• The company has the potential to raise significantly more capital, up to $29.68 million, under the same terms.
• The transaction was completed without incurring placement agent fees or commissions.

Negatives

• The initial capital raise of $116,000 is relatively small.
• There is no guarantee that the company will be able to raise the additional $29.68 million.

Risks

• The company's ability to raise additional capital is not guaranteed.
• Future sales are dependent on market conditions and investor interest.
• The company may not be able to secure additional funding on the same terms.

Future Outlook

Aclarion intends to potentially raise additional capital through future sales under the same terms, but there is no guarantee that these sales will occur.

Management Comments

• The company desires to consummate one or more additional sales in the future.
• The company cannot guarantee that any such sales will occur in the future.

Industry Context

At-the-market offerings are a common method for companies to raise capital, particularly for smaller companies seeking to avoid the costs and complexities of traditional underwritten offerings. This approach allows Aclarion to access capital as needed, without the need for a large, single offering.

Comparison to Industry Standards

• At-the-market offerings are frequently used by small-cap and micro-cap companies to raise capital, often in smaller increments.
• The size of this offering, $116,000, is relatively small compared to typical capital raises, which can range from millions to billions of dollars for larger companies.
• The potential for an additional $29.68 million is more in line with typical capital raises for companies of this size, but it is not guaranteed.
• Comparable companies in the biotech or medical device space often use similar methods to raise capital, especially when they are in the early stages of development or commercialization.

Stakeholder Impact

• Shareholders may experience dilution if additional shares are sold.
• The company's ability to fund operations and growth is improved by the capital raise.

Next Steps

• The company may conduct additional sales of common stock under the existing offering statement.
• Future sales will be disclosed through subsequent Prospectus Supplements.

Key Dates

Keywords

capital raise, at-the-market offering, common stock, subscription agreement, institutional investor, securities, Nasdaq